Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3301 AL 3315

Online cognitive testing in Parkinson's disease: advantages and challenges

Binoy S, Lithwick Algon A, Ben Adiva Y, Montaser-Kouhsari L, Saban W.

Front Neurol. 2024 Apr 8;15:1363513. doi: 10.3389/fneur.2024.1363513. eCollection 2024.

New Perspectives of Deep Brain Stimulation Indications for Parkinson's Disease: A Critical Review

Barbosa RMG, Soares MC, Portela DMMC, Guimarães TG, Cury RG.

Brain Sci. 2024 Jun 26;14(7):638. doi: 10.3390/brainsci14070638.

Convergence of Neuroinflammation, Microbiota, and Parkinson's Disease: Therapeutic Insights and Prospects

Domínguez Rojo N, Blanco Benítez M, Cava R, Fuentes JM, Canales Cortés S, González Polo RA.

Int J Mol Sci. 2024 Oct 29;25(21):11629. doi: 10.3390/ijms252111629.

Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease

Xiao Z, Wang X, Pan X, Xie J, Xu H.

Exp Neurol. 2024 Feb;372:114614. doi: 10.1016/j.expneurol.2023.114614. Epub 2023 Nov 23.

Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease

Kou L, Chi X, Sun Y, Yin S, Wu J, Zou W, Wang Y, Jin Z, Huang J, Xiong N, Xia Y, Wang T.

Ageing Res Rev. 2024 Mar;95:102232. doi: 10.1016/j.arr.2024.102232. Epub 2024 Feb 15.

Emerging wearable technologies for multisystem monitoring and treatment of Parkinson's disease: a narrative review

Kehnemouyi YM, Coleman TP, Tass PA.

Front Netw Physiol. 2024 Feb 13;4:1354211. doi: 10.3389/fnetp.2024.1354211. eCollection 2024.

Emerging insights into Lipocalin-2: Unraveling its role in Parkinson's Disease

Qiu R, Cai Y, Su Y, Fan K, Sun Z, Zhang Y.

Biomed Pharmacother. 2024 Aug;177:116947. doi: 10.1016/j.biopha.2024.116947. Epub 2024 Jun 19.

Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease

Zhao Y, Lin M, Zhai F, Chen J, Jin X.

Pharmaceuticals (Basel). 2024 Jun 14;17(6):782. doi: 10.3390/ph17060782.

Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis

Wang S, Xiong Z, Cui Y, Fan F, Zhang S, Jia R, Hu Y, Li L, Zhang X, Han F.

Mov Disord. 2024 Mar;39(3):585-595. doi: 10.1002/mds.29714. Epub 2024 Jan 21.

The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research

Cibulka M, Brodnanova M, Halasova E, Kurca E, Kolisek M, Grofik M.

Int J Mol Sci. 2024 Aug 1;25(15):8425. doi: 10.3390/ijms25158425.

Molecular mechanism of cognitive impairment associated with Parkinson's disease: A stroke perspective

Gupta S, Khan J, Ghosh S.

Life Sci. 2024 Jan 15;337:122358. doi: 10.1016/j.lfs.2023.122358. Epub 2023 Dec 19.

Identifying Subtle Motor Deficits Before Parkinson's Disease is Diagnosed: What to Look for?

Maetzler W, Mirelman A, Pilotto A, Bhidayasiri R.

J Parkinsons Dis. 2024;14(s2):S287-S296. doi: 10.3233/JPD-230350.

Computer Vision for Parkinson's Disease Evaluation: A Survey on Finger Tapping

Amo-Salas J, Olivares-Gil A, García-Bustillo Á, García-García D, Arnaiz-González Á, Cubo E.

Healthcare (Basel). 2024 Feb 8;12(4):439. doi: 10.3390/healthcare12040439.

Considerations on How to Prevent Parkinson's Disease Through Exercise

Oosterhof TH, Darweesh SKL, Bloem BR, de Vries NM.

J Parkinsons Dis. 2024;14(s2):S395-S406. doi: 10.3233/JPD-240091.

Neuroplasticity in Parkinson's disease

Popescu BO, Batzu L, Ruiz PJG, Tulbă D, Moro E, Santens P.

J Neural Transm (Vienna). 2024 Nov;131(11):1329-1339. doi: 10.1007/s00702-024-02813-y. Epub 2024 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias